Viral vector is a tool that molecular biologists use to deliver genetic material into cells.This process is performed usingviruses as vectors of the genetic material to be transferred into host cells. The delivery of genes by a vector is calledtransduction while the host cells are called transduced after an infection by viral vectors. Viral vector purification is theprocess by which viral particles are isolated from the host cell in which it has grown.This is done after the process ofgene delivery in the host cell has occurred.The common methods of viral vector purfication are chromatography andcentrifugation.
The global Viral Vector Purification market is projected to reach US$ 264.4 million in 2029, increasing from US$ 197 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Viral Vector Purification 91制片厂.
Gene therapy holds great promise for treating genetic disorders, cancer, and other diseases at the genetic level. Viral vectors, such as adeno-associated viruses (AAV) and lentiviruses, are commonly used to deliver therapeutic genes to target cells. As the field of gene therapy continues to advance and gain regulatory approval, the demand for viral vector purification technologies increases. The biopharmaceutical industry is heavily invested in researching and developing advanced therapies, including gene and cell therapies. Viral vectors are an essential component of these therapies, making their purification a critical step in the manufacturing process. The growing investments in biopharmaceutical R&D drive the demand for viral vector purification technologies that can efficiently and effectively remove impurities and contaminants. Vaccines are crucial for preventing and controlling infectious diseases. Viral vectors, such as adenoviruses and vesicular stomatitis viruses (VSV), are utilized in vaccine development to deliver antigens and stimulate an immune response. With a growing focus on vaccination programs to combat diseases like COVID-19 and emerging infectious diseases, the demand for viral vector purification technologies to produce safe and effective viral vector-based vaccines is increasing. The production of viral vectors for clinical and commercial use is subject to regulatory guidelines and quality standards set by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These guidelines emphasize the need for robust purification processes to ensure the safety, purity, and potency of viral vectors. Adhering to these guidelines drives the adoption of viral vector purification technologies. The viral vector purification market is influenced by ongoing technological advancements in purification techniques and tools. Various chromatography, filtration, and separation techniques have been developed to effectively purify viral vectors from impurities, contaminants, and host cell components. These advancements aim to improve the recovery, purity, and scalability of viral vector purification processes, meeting the increasing demands of the industry. Collaboration between academic institutions, research organizations, and biopharmaceutical companies is driving advancements in viral vector purification. Collaborative efforts contribute to the development of innovative purification techniques and technologies, fostering the growth of the viral vector purification market. The increasing prevalence of genetic diseases globally creates a need for effective gene therapy approaches. Viral vectors are essential tools in delivering therapeutic genes to correct genetic abnormalities. As the awareness and understanding of genetic diseases grow, the demand for viral vectors and their purification technologies is expected to surge.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Viral Vector Purification market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Applied Biological Materials Inc.
Creative Biolabs
Bio-Rad Laboratories, Inc.
Sirion-Biotech GmbH
Merck KGaA
FUJIFILM Diosynth Biotechnologies
Batavia BiosciencesB.v.Agilent Technologies, Inc.
ProBioGen AG
Takara Bio lnc.
Novartis
Repligen
Segment by Type
Retroviral Vectors
Vaccine Virus
Adenoviral Vectors
Adeno-Associated Viral Vectors
Lentivirus
Others
Segment by Application
Gene Therapy
Cell Therapy
Vaccinology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Viral Vector Purification report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Purification Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Retroviral Vectors
1.2.3 Vaccine Virus
1.2.4 Adenoviral Vectors
1.2.5 Adeno-Associated Viral Vectors
1.2.6 Lentivirus
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral Vector Purification Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Gene Therapy
1.3.3 Cell Therapy
1.3.4 Vaccinology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Purification Market Perspective (2018-2029)
2.2 Viral Vector Purification Growth Trends by Region
2.2.1 Global Viral Vector Purification Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Viral Vector Purification Historic Market Size by Region (2018-2023)
2.2.3 Viral Vector Purification Forecasted Market Size by Region (2024-2029)
2.3 Viral Vector Purification Market Dynamics
2.3.1 Viral Vector Purification Industry Trends
2.3.2 Viral Vector Purification Market Drivers
2.3.3 Viral Vector Purification Market Challenges
2.3.4 Viral Vector Purification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Purification Players by Revenue
3.1.1 Global Top Viral Vector Purification Players by Revenue (2018-2023)
3.1.2 Global Viral Vector Purification Revenue Market Share by Players (2018-2023)
3.2 Global Viral Vector Purification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Purification Revenue
3.4 Global Viral Vector Purification Market Concentration Ratio
3.4.1 Global Viral Vector Purification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Purification Revenue in 2022
3.5 Viral Vector Purification Key Players Head office and Area Served
3.6 Key Players Viral Vector Purification Product Solution and Service
3.7 Date of Enter into Viral Vector Purification Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Purification Breakdown Data by Type
4.1 Global Viral Vector Purification Historic Market Size by Type (2018-2023)
4.2 Global Viral Vector Purification Forecasted Market Size by Type (2024-2029)
5 Viral Vector Purification Breakdown Data by Application
5.1 Global Viral Vector Purification Historic Market Size by Application (2018-2023)
5.2 Global Viral Vector Purification Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Vector Purification Market Size (2018-2029)
6.2 North America Viral Vector Purification Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Viral Vector Purification Market Size by Country (2018-2023)
6.4 North America Viral Vector Purification Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Purification Market Size (2018-2029)
7.2 Europe Viral Vector Purification Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Viral Vector Purification Market Size by Country (2018-2023)
7.4 Europe Viral Vector Purification Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Purification Market Size (2018-2029)
8.2 Asia-Pacific Viral Vector Purification Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Viral Vector Purification Market Size by Region (2018-2023)
8.4 Asia-Pacific Viral Vector Purification Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Purification Market Size (2018-2029)
9.2 Latin America Viral Vector Purification Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Viral Vector Purification Market Size by Country (2018-2023)
9.4 Latin America Viral Vector Purification Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Purification Market Size (2018-2029)
10.2 Middle East & Africa Viral Vector Purification Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Viral Vector Purification Market Size by Country (2018-2023)
10.4 Middle East & Africa Viral Vector Purification Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Applied Biological Materials Inc.
11.1.1 Applied Biological Materials Inc. Company Detail
11.1.2 Applied Biological Materials Inc. Business Overview
11.1.3 Applied Biological Materials Inc. Viral Vector Purification Introduction
11.1.4 Applied Biological Materials Inc. Revenue in Viral Vector Purification Business (2018-2023)
11.1.5 Applied Biological Materials Inc. Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Detail
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Viral Vector Purification Introduction
11.2.4 Creative Biolabs Revenue in Viral Vector Purification Business (2018-2023)
11.2.5 Creative Biolabs Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Detail
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Viral Vector Purification Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Viral Vector Purification Business (2018-2023)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Sirion-Biotech GmbH
11.4.1 Sirion-Biotech GmbH Company Detail
11.4.2 Sirion-Biotech GmbH Business Overview
11.4.3 Sirion-Biotech GmbH Viral Vector Purification Introduction
11.4.4 Sirion-Biotech GmbH Revenue in Viral Vector Purification Business (2018-2023)
11.4.5 Sirion-Biotech GmbH Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Detail
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Viral Vector Purification Introduction
11.5.4 Merck KGaA Revenue in Viral Vector Purification Business (2018-2023)
11.5.5 Merck KGaA Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Purification Business (2018-2023)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Batavia BiosciencesB.v.Agilent Technologies, Inc.
11.7.1 Batavia BiosciencesB.v.Agilent Technologies, Inc. Company Detail
11.7.2 Batavia BiosciencesB.v.Agilent Technologies, Inc. Business Overview
11.7.3 Batavia BiosciencesB.v.Agilent Technologies, Inc. Viral Vector Purification Introduction
11.7.4 Batavia BiosciencesB.v.Agilent Technologies, Inc. Revenue in Viral Vector Purification Business (2018-2023)
11.7.5 Batavia BiosciencesB.v.Agilent Technologies, Inc. Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Detail
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Viral Vector Purification Introduction
11.8.4 ProBioGen AG Revenue in Viral Vector Purification Business (2018-2023)
11.8.5 ProBioGen AG Recent Development
11.9 Takara Bio lnc.
11.9.1 Takara Bio lnc. Company Detail
11.9.2 Takara Bio lnc. Business Overview
11.9.3 Takara Bio lnc. Viral Vector Purification Introduction
11.9.4 Takara Bio lnc. Revenue in Viral Vector Purification Business (2018-2023)
11.9.5 Takara Bio lnc. Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Viral Vector Purification Introduction
11.10.4 Novartis Revenue in Viral Vector Purification Business (2018-2023)
11.10.5 Novartis Recent Development
11.11 Repligen
11.11.1 Repligen Company Detail
11.11.2 Repligen Business Overview
11.11.3 Repligen Viral Vector Purification Introduction
11.11.4 Repligen Revenue in Viral Vector Purification Business (2018-2023)
11.11.5 Repligen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Applied Biological Materials Inc.
Creative Biolabs
Bio-Rad Laboratories, Inc.
Sirion-Biotech GmbH
Merck KGaA
FUJIFILM Diosynth Biotechnologies
Batavia BiosciencesB.v.Agilent Technologies, Inc.
ProBioGen AG
Takara Bio lnc.
Novartis
Repligen
听
听
*If Applicable.
